China Gene Therapy Market Research Report 2018

March 2018 | 99 pages | ID: CAF8311FF80EN
QYResearch

Abstracts

The global Gene Therapy market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

China plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%.

This report studies the Gene Therapy development status and future trend in China, focuses on top players in China, also splits Gene Therapy by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in China market include

• Sangamo
• Spark Therapeutics
• Dimension Therapeutics
• Avalanche Bio
• Celladon
• Vical
• Advantagene

Geographically, this report splits the China market into six regions,

• South China
• East China
• Southwest China
• Northeast China
• North China
• Central China
• Northwest China

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into

• Ex vivo
• In vivo

On the basis of the end users/application, this report covers

• Cancer Diseases
• Monogenic Diseases
• Infectious Diseases
• Cardiovascular Diseases
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

China Gene Therapy Market Research Report 2018

1 GENE THERAPY OVERVIEW

1.1 Product Overview and Scope of Gene Therapy
1.2 Classification of Gene Therapy by Product Category
  1.2.1 China Gene Therapy Sales (K Units) Comparison by Type (2013-2025)
  1.2.2 China Gene Therapy Sales (K Units) Market Share by Type in 2017
  1.2.3 Ex vivo
  1.2.4 In vivo
1.3 China Gene Therapy Market by Application/End Users
  1.3.1 China Gene Therapy Sales (K Units) and Market Share Comparison by Applications (2013-2025)
  1.3.2 Cancer Diseases
  1.3.3 Monogenic Diseases
  1.3.4 Infectious Diseases
  1.3.5 Cardiovascular Diseases
  1.3.6 Others
1.4 China Gene Therapy Market by Region
  1.4.1 China Gene Therapy Market Size (Million USD) Comparison by Region (2013-2025)
  1.4.2 South China Gene Therapy Status and Prospect (2013-2025)
  1.4.3 East China Gene Therapy Status and Prospect (2013-2025)
  1.4.4 Southwest China Gene Therapy Status and Prospect (2013-2025)
  1.4.5 Northeast China Gene Therapy Status and Prospect (2013-2025)
  1.4.6 North China Gene Therapy Status and Prospect (2013-2025)
  1.4.7 Central China Gene Therapy Status and Prospect (2013-2025)
1.5 China Market Size (Sales and Revenue) of Gene Therapy (2013-2025)
  1.5.1 China Gene Therapy Sales (K Units) and Growth Rate (%)(2013-2025)
  1.5.2 China Gene Therapy Revenue (Million USD) and Growth Rate (%)(2013-2025)

2 CHINA GENE THERAPY MARKET COMPETITION BY PLAYERS/MANUFACTURERS

2.1 China Gene Therapy Sales and Market Share of Key Players/Manufacturers (2013-2018)
2.2 China Gene Therapy Revenue and Share by Players/Manufacturers (2013-2018)
2.3 China Gene Therapy Average Price (USD/Unit) by Players/Manufacturers (2013-2018)
2.4 China Gene Therapy Market Competitive Situation and Trends
  2.4.1 China Gene Therapy Market Concentration Rate
  2.4.2 China Gene Therapy Market Share of Top 3 and Top 5 Players/Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion in China Market
2.5 China Players/Manufacturers Gene Therapy Manufacturing Base Distribution, Sales Area, Product Types

3 CHINA GENE THERAPY SALES AND REVENUE BY REGION (2013-2018)

3.1 China Gene Therapy Sales (K Units) and Market Share by Region (2013-2018)
3.2 China Gene Therapy Revenue (Million USD) and Market Share by Region (2013-2018)
3.3 China Gene Therapy Price (USD/Unit) by Regions (2013-2018)

4 CHINA GENE THERAPY SALES AND REVENUE BY TYPE/ PRODUCT CATEGORY (2013-2018)

4.1 China Gene Therapy Sales (K Units) and Market Share by Type/ Product Category (2013-2018)
4.2 China Gene Therapy Revenue (Million USD) and Market Share by Type (2013-2018)
4.3 China Gene Therapy Price (USD/Unit) by Type (2013-2018)
4.4 China Gene Therapy Sales Growth Rate (%) by Type (2013-2018)

5 CHINA GENE THERAPY SALES BY APPLICATION (2013-2018)

5.1 China Gene Therapy Sales (K Units) and Market Share by Application (2013-2018)
5.2 China Gene Therapy Sales Growth Rate (%) by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 CHINA GENE THERAPY PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Sangamo
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Gene Therapy Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Sangamo Gene Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Spark Therapeutics
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Gene Therapy Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Spark Therapeutics Gene Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Dimension Therapeutics
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Gene Therapy Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Dimension Therapeutics Gene Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Avalanche Bio
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Gene Therapy Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Avalanche Bio Gene Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Celladon
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Gene Therapy Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Celladon Gene Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Vical
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Gene Therapy Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Vical Gene Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Advantagene
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Gene Therapy Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Advantagene Gene Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.7.4 Main Business/Business Overview

7 GENE THERAPY MANUFACTURING COST ANALYSIS

7.1 Gene Therapy Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Gene Therapy

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Gene Therapy Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Gene Therapy Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 CHINA GENE THERAPY MARKET SIZE (SALES AND REVENUE) FORECAST (2018-2025)

11.1 China Gene Therapy Sales (K Units), Revenue (Million USD) Forecast (2018-2025)
11.2 China Gene Therapy Sales (K Units) Forecast by Type (2018-2025)
11.3 China Gene Therapy Sales (K Units) Forecast by Application (2018-2025)
11.4 China Gene Therapy Sales (K Units) Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 METHODOLOGY AND DATA SOURCE

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Global and China Market Size (Million USD) Comparison (2013-2025)
Table Gene Therapy Sales (K Units) and Revenue (Million USD) Market Split by Product Type
Table Gene Therapy Sales (K Units) by Application (2013-2025)
Figure Product Picture of Gene Therapy
Table China Gene Therapy Sales (K Units) and Growth Rate (%) Comparison by Types (Product Category) (2013-2025)
Figure China Gene Therapy Sales Volume Market Share by Types in 2017
Figure Ex vivo Product Picture
Figure In vivo Product Picture
Figure China Gene Therapy Sales (K Units) Comparison by Application (2013-2025)
Figure China Sales Market Share (%) of Gene Therapy by Application in 2017
Figure Cancer Diseases Examples
Table Key Downstream Customer in Cancer Diseases
Figure Monogenic Diseases Examples
Table Key Downstream Customer in Monogenic Diseases
Figure Infectious Diseases Examples
Table Key Downstream Customer in Infectious Diseases
Figure Cardiovascular Diseases Examples
Table Key Downstream Customer in Cardiovascular Diseases
Figure Others Examples
Table Key Downstream Customer in Others
Figure South China Gene Therapy Revenue (Million USD) and Growth Rate (2013-2025)
Figure East China Gene Therapy Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest China Gene Therapy Revenue (Million USD) and Growth Rate (2013-2025)
Figure Northeast China Gene Therapy Revenue (Million USD) and Growth Rate (2013-2025)
Figure North China Gene Therapy Revenue (Million USD) and Growth Rate (2013-2025)
Figure Central China Gene Therapy Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Gene Therapy Sales (K Units) and Growth Rate (%)(2013-2025)
Figure China Gene Therapy Revenue (Million USD) and Growth Rate (%)(2013-2025)
Table China Gene Therapy Sales of Key Players/Manufacturers (2013-2018)
Table China Gene Therapy Sales Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 China Gene Therapy Sales Share (%) by Players/Manufacturers
Figure 2017 China Gene Therapy Sales Share (%) by Players/Manufacturers
Table China Gene Therapy Revenue by Players/Manufacturers (2013-2018)
Table China Gene Therapy Revenue Market Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 China Gene Therapy Revenue Market Share (%) by Players/Manufacturers
Figure 2017 China Gene Therapy Revenue Market Share (%) by Players/Manufacturers
Table China Market Gene Therapy Average Price of Key Players/Manufacturers (2013-2018)
Figure China Market Gene Therapy Average Price of Key Players/Manufacturers in 2017
Figure China Gene Therapy Market Share of Top 3 Players/Manufacturers
Figure China Gene Therapy Market Share of Top 5 Players/Manufacturers
Table China Players/Manufacturers Gene Therapy Manufacturing Base Distribution and Sales Area
Table China Players/Manufacturers Gene Therapy Product Category
Table China Gene Therapy Sales (K Units) by Regions (2013-2018)
Table China Gene Therapy Sales Share (%) by Regions (2013-2018)
Figure China Gene Therapy Sales Share (%) by Regions (2013-2018)
Figure China Gene Therapy Sales Market Share (%) by Regions in 2017
Table China Gene Therapy Revenue (Million USD) and Market Share by Regions (2013-2018)
Table China Gene Therapy Revenue Market Share (%) by Regions (2013-2018)
Figure China Gene Therapy Revenue Market Share (%) by Regions (2013-2018)
Figure China Gene Therapy Revenue Market Share (%) by Regions in 2017
Table China Gene Therapy Price (USD/Unit) by Regions (2013-2018)
Table China Gene Therapy Sales (K Units) by Type (2013-2018)
Table China Gene Therapy Sales Share (%) by Type (2013-2018)
Figure China Gene Therapy Sales Share (%) by Type (2013-2018)
Figure China Gene Therapy Sales Market Share (%) by Type in 2017
Table China Gene Therapy Revenue (Million USD) and Market Share by Type (2013-2018)
Table China Gene Therapy Revenue Market Share (%) by Type (2013-2018)
Figure Revenue Market Share of Gene Therapy by Type (2013-2018)
Figure Revenue Market Share of Gene Therapy by Type in 2017
Table China Gene Therapy Price (USD/Unit) by Types (2013-2018)
Figure China Gene Therapy Sales Growth Rate (%) by Type (2013-2018)
Table China Gene Therapy Sales (K Units) by Applications (2013-2018)
Table China Gene Therapy Sales Market Share (%) by Applications (2013-2018)
Figure China Gene Therapy Sales Market Share (%) by Application (2013-2018)
Figure China Gene Therapy Sales Market Share (%) by Application in 2017
Table China Gene Therapy Sales Growth Rate (%) by Application (2013-2018)
Figure China Gene Therapy Sales Growth Rate (%) by Application (2013-2018)
Table Sangamo Gene Therapy Basic Information List
Table Sangamo Gene Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Sangamo Gene Therapy Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Sangamo Gene Therapy Sales Market Share (%) in China (2013-2018)
Figure Sangamo Gene Therapy Revenue Market Share (%) in China (2013-2018)
Table Spark Therapeutics Gene Therapy Basic Information List
Table Spark Therapeutics Gene Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Spark Therapeutics Gene Therapy Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Spark Therapeutics Gene Therapy Sales Market Share (%) in China (2013-2018)
Figure Spark Therapeutics Gene Therapy Revenue Market Share (%) in China (2013-2018)
Table Dimension Therapeutics Gene Therapy Basic Information List
Table Dimension Therapeutics Gene Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Dimension Therapeutics Gene Therapy Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Dimension Therapeutics Gene Therapy Sales Market Share (%) in China (2013-2018)
Figure Dimension Therapeutics Gene Therapy Revenue Market Share (%) in China (2013-2018)
Table Avalanche Bio Gene Therapy Basic Information List
Table Avalanche Bio Gene Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Avalanche Bio Gene Therapy Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Avalanche Bio Gene Therapy Sales Market Share (%) in China (2013-2018)
Figure Avalanche Bio Gene Therapy Revenue Market Share (%) in China (2013-2018)
Table Celladon Gene Therapy Basic Information List
Table Celladon Gene Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Celladon Gene Therapy Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Celladon Gene Therapy Sales Market Share (%) in China (2013-2018)
Figure Celladon Gene Therapy Revenue Market Share (%) in China (2013-2018)
Table Vical Gene Therapy Basic Information List
Table Vical Gene Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Vical Gene Therapy Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Vical Gene Therapy Sales Market Share (%) in China (2013-2018)
Figure Vical Gene Therapy Revenue Market Share (%) in China (2013-2018)
Table Advantagene Gene Therapy Basic Information List
Table Advantagene Gene Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Advantagene Gene Therapy Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Advantagene Gene Therapy Sales Market Share (%) in China (2013-2018)
Figure Advantagene Gene Therapy Revenue Market Share (%) in China (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Gene Therapy
Figure Manufacturing Process Analysis of Gene Therapy
Figure Gene Therapy Industrial Chain Analysis
Table Raw Materials Sources of Gene Therapy Major Players/Manufacturers in 2017
Table Major Buyers of Gene Therapy
Table Distributors/Traders List
Figure China Gene Therapy Sales (K Units) and Growth Rate (%) Forecast (2018-2025)
Figure China Gene Therapy Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure China Gene Therapy Price (USD/Unit) Trend Forecast (2018-2025)
Table China Gene Therapy Sales (K Units) Forecast by Type (2018-2025)
Figure China Gene Therapy Sales (K Units) Forecast by Type (2018-2025)
Figure China Gene Therapy Sales Volume Market Share Forecast by Type in 2025
Table China Gene Therapy Sales (K Units) Forecast by Application (2018-2025)
Figure China Gene Therapy Sales Volume Market Share Forecast by Application (2018-2025)
Figure China Gene Therapy Sales Volume Market Share Forecast by Application in 2025
Table China Gene Therapy Sales (K Units) Forecast by Regions (2018-2025)
Table China Gene Therapy Sales Volume Share Forecast by Regions (2018-2025)
Figure China Gene Therapy Sales Volume Share Forecast by Regions (2018-2025)
Figure China Gene Therapy Sales Volume Share Forecast by Regions in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources